(Q45303735)

11 December 2017

title

Basal ganglia disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6128460

10 August 2023

1

C D Marsden

1 reference

11 December 2017

C. D. Marsden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6128460

10 August 2023

language of work or name

English

0 references

publication date

1 November 1982

1 reference

11 December 2017

20 November 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6128460

full work available at URL

10 August 2023

https://api.elsevier.com/content/article/PII:S0140673682927970?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92797-0

https://api.elsevier.com/content/article/PII:S0140673682927970?httpAccept=text/plain

10 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92797-0

10 August 2023

1 reference

11 December 2017

volume

2

1 reference

11 December 2017

issue

8308

1 reference

11 December 2017

page(s)

1141-1147

1 reference

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Is the mesocortical dopaminergic system involved in Parkinson disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Methionine-enkephalin deficiency in brains of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Dementia in Parkinson disease: A neuropathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Twin study of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

The role of D-1 and D-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Alterations in 3H-GABA binding in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Alterations of brain neurotransmitter receptor binding in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Huntington's chorea: post mortem activity of enzymes involved in cerebral glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Glutamine synthetase activity in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Abnormal Glutamate Metabolism in an Adult-Onset Degenerative Neurological Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992797-0

7 January 2021

Pathology of Parkinson's Disease

series ordinal

3

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92797-0

10 August 2023

Identifiers

1 reference

11 December 2017

1 reference